| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911474 | Lung Cancer | 2012 | 4 Pages |
Abstract
Vatalanib as a single agent with this dose and schedule does not warrant further study in this disease.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Thierry Jahan, Lin Gu, Robert Kratzke, Arkadiusz Dudek, Gregory A. Otterson, Xiaofei Wang, Mark Green, Everett E. Vokes, Hedy Lee Kindler,